Health Monitoring in Mayotte. Bulletin of February 20, 2026.

Key Points

Chikungunya

  • Significant increase in chikungunya cases in week 07-2026, with 74 cases recorded, representing more than 40% of all cases reported since the beginning of the year (175 cases). Transition to phase 2B of the ORSEC arbovirus response plan in week 07, corresponding to the pre-epidemic phase

Bronchiolitis

  • The bronchiolitis epidemic continues at a high intensity level throughout the country

Smallpox B (Mpox)

  • Ten confirmed cases of Mpox have been reported in Mayotte since the beginning of 2026, including 7 locally acquired cases and 3 cases imported from Madagascar. No new cases of Mpox in S08.

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?